Overexpression of p18INK4C in LLC-PK1 cells increases resistance to cisplatin-induced apoptosis

Pediatric Nephrology

Volumn 26, Issue 8, 2011, Pages 1291-1301

  Zhang, Yi ^a   Yuan, Li ^a   Fu, Lili ^a   Liu, Chunyan ^a   Liu, Dongmei ^a   Mei, Changlin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Acute kidney injury; Cisplatin; Cyclin dependent kinase inhibitor; P18; Transfection

Indexed keywords

CASPASE 3; CISPLATIN; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2C; ENZYME INHIBITOR;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; KIDNEY NECROSIS; KIDNEY TUBULE CELL; PRIORITY JOURNAL; RENAL PROTECTION; ACUTE KIDNEY FAILURE; ANIMAL; CELL CYCLE; CELL LINE; CELL SEPARATION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FLOW CYTOMETRY; METABOLISM; MOUSE; PHYSIOLOGY; SIGNAL TRANSDUCTION; SWINE; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SEPARATION; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P18; ENZYME INHIBITORS; FLOW CYTOMETRY; MICE; SIGNAL TRANSDUCTION; SWINE; TRANSFECTION;

EID: 80052496416     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-011-1877-y     Document Type: Article

References (63)

1. Waikar SS, Liu KD, Chertow GM (2008) Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 3:844-861.
2. Okusa MD (2002) The inflammatory cascade in acute ischemic renal failure. Nephron 90:133-138. (Pubitemid 34701986)
3. Ramesh G, Reeves WB (2002) TNF- mediates cytokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest 110:835-842.
4. Oh DJ, Dursun B, He Z, Lu L, Hoke TS, Ljubanovic D, Faubel S, Edelstein CL (2008) Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 294:F264-F271.
5. Del Rio M, Imam A, DeLeon M, Gomez G, Mishra J, Ma Q, Parikh S, Devarajan P (2004) The death domain of kidney ankyrin interacts with Fas and promotes Fas-mediated cell death in renal epithelia. J Am Soc Nephrol 15:41-51. (Pubitemid 38020696)
6. Devarajan P (2006) Update on mechanisms of ischemic acute kidney injury. J Am Soc Nephrol 17:1503-1520. (Pubitemid 43841396)
7. Burne MJ, Daniels F, El Ghandour A, Mauiyyedi S, Colvin RBO'Donnell MP, Rabb H (2001) Identification of the CD4+ T cellas a major pathogenic factor in ischemic acute renal failure. J Clin Invest 108:1283-1290. (Pubitemid 33107755)
8. Jiang M, Pabla N, Murphy RF, Yang T, Yin XM, Degenhardt K, White E, Dong Z (2007) Nutlin-3 protects kidney cells during cisplatin therapy by suppressing Bax/Bak activation. J Biol Chem 282:2636-2645. (Pubitemid 47076791)
9. Wei Q, Dong G, Yang T, Megyesi J, Price PM, Dong Z (2007) Activation and involvement of p53 in cisplatin-induced nephrotoxicity. Am J Physiol Renal Physiol 293:F1282-F1291. (Pubitemid 47583963)
10. Cummings BS, Schnellmann RG (2002) Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther 302:8-17. (Pubitemid 34680415)
11. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G (2009) Classification of cell death: recommendations of the nomenclature committee on cell death 2009. Cell Death Differ 16:3-11.
12. Periyasamy-Thandavan S, Jiang M, Wei Q, Smith R, Yin XM, Dong Z (2008) Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int 74:631-640.
13. Shankland SJ, Wolf G (2000) Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278:F515-F529. (Pubitemid 30215229)
14. Morgan DO (1995) Principles of CDK regulation. Nature 374:131-134.
15. Peter M, Herskowitz I (1994) Joining the complex: cyclindependent kinase inhibitory proteins and the cell cycle. Cell 79:181-184. (Pubitemid 24324907)
16. Weinert T (1998) DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell 94:555- 558. (Pubitemid 28427574)
17. Price PM, Safirstein RL, Megyesi J (2009) The cell cycle and acute kidney injury. Kidney Int 76:604-613.
18. Megyesi J, Safirstein RL, Price PM (1998) Induction of p21WAF1/CIP1/SDI1 in kidney tubule cells affects the course of cisplatin-induced acute renal failure. J Clin Invest 101:777-782. (Pubitemid 28096074)
19. Nowak G, Price PM, Schnellmann RG (2003) Lack of a functional p21WAF1/CIP1 gene accelerates caspase-independent apoptosis induced by cisplatin in renal cells. Am J Physiol Renal Physiol 285:F440-F450. (Pubitemid 37010854)
20. Yu F, Megyesi J, Safirstein RL, Price PM (2005) Identification of the functional domain of p21(WAF1/CIP1) that protects cells from cisplatin cytotoxicity. Am J Physiol Renal Physiol 289:F514- F520. (Pubitemid 41208465)
21. Megyesi J, Andrade L, Vieira JM Jr, Safirstein RL, Price PM (2002) Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol 283:F810-F816. (Pubitemid 35033969)
22. Price PM, Yu F, Kaldis P, Aleem E, Nowak G, Safirstein RL, Megyesi J (2006) Dependence of cisplatin-induced cell death in vitro and in vivo on cyclin-dependent kinase 2. J Am Soc Nephrol 17:2434-2442. (Pubitemid 44300959)
23. Yu F, Megyesi J, Price PM (2008) Cytoplasmic initiation of cisplatin cytotoxicity. Am J Physiol Renal Physiol 295:F44-F452.
24. Price PM, Safirstein RL, Megyesi J (2004) Protection of renal cells from cisplatin toxicity by cell cycle inhibitors. Am J Physiol Renal Physiol 286:F378-F384. (Pubitemid 38141683)
25. Hengst L, Reed SI (1998) Inhibitors of the Cip/Kip family. Curr Top Microbiol Immunol 227:25-41. (Pubitemid 28023060)
26. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev 9:1149-1163.
27. Cordon-Cardo C (1995) Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia. Am J Pathol 147:545-560.
28. Cánepa ET, Scassa ME, Ceruti JM, Marazita MC, Carcagno AL, Sirkin PF, Ogara MF (2007) INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions. IUBMB Life 59:419-426. (Pubitemid 47123998)
29. Guan KL, Jenkins CW, Li Y, Nichols MA, Wu X, O'Keefe CL, Matera AG, Xiong Y (1994) Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939-2952.
30. Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ (1995) Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672-2681.
31. Choi KS, Eom YW, Kang Y, Ha MJ, Rhee H, Yoon JW, Kim SJ (1999) Cdc2 and Cdk2 kinase activated by transforming growth factor-beta1 trigger apoptosis through the phosphorylation of retinoblastoma protein in FaO hepatoma cells. J Biol Chem 274:31775-31783.
32. Wang D, Lippard SJ (2005) Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 4:307-320. (Pubitemid 41130944)
33. Siddik ZH (2003) Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene 22:7265-7279. (Pubitemid 37487159)
34. Pabla N, Dong Z (2008) Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 73:994-1007. (Pubitemid 351543900)
35. Lieberthal W, Triaca V, Levine J (1996) Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis. Am J Physiol 270:F700-F708.
36. Razzaque MS, Koji T, Kumatori A, Taguchi T (1999) Cisplatininduced apoptosis in human proximal tubular epithelial cells is associated with the activation of the Fas/Fas ligand system. Histochem Cell Biol 111:359-365. (Pubitemid 29274005)
37. Seth R, Yang C, Kaushal V, Shah SV, Kaushal GP (2005) p53- dependent caspase-2 activiation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J Biol Chem 280:31230-31239. (Pubitemid 41291860)
38. Park MS, De Leon M, Devarajan P (2002) Cisplatin induces apoptosis in LLC-PK1 cells via activation of mitochondrial pathways. J Am Soc Nephrol 13:858-865. (Pubitemid 34274081)
39. Huang Q, Dunn RT 2nd, Jayadev S, DiSorbo O, Pack FD, Farr SB, Stoll RE, Blanchard KT (2001) Assessment of cisplatininduced nephrotoxicity by microarray technology. Toxicol Sci 63:196-207. (Pubitemid 32982793)
40. Muruganandan S, Cribb AE (2006) Calpain-induced endoplasmic reticulum stress and cell death following cytotoxic damage to renal cells. Toxicol Sci 94:118-128. (Pubitemid 44542335)
41. Cribb AE, Peyrou M, Muruganandan S, Schneider L (2005) The endoplasmic reticulum in xenobiotic toxicity. Drug Metab Rev 37:405-442. (Pubitemid 41434157)
42. Peyrou M, Hanna PE, Cribb AE (2007) Cisplatin, gentamicin, and p-aminophenol induce markers of endoplasmic reticulum stress in the rat kidneys. Toxicol Sci 99:346-353. (Pubitemid 47250391)
43. Liu H, Baliga R (2005) Endoplasmic reticulum stress-associated caspase 12 mediates cisplatin-induced LLC-PK1 cell apoptosis. J Am Soc Nephrol 16:1985-1992. (Pubitemid 41716429)
44. Bernales S, Papa FR, Walter P (2006) Intracellular signaling by the unfolded protein response. Annu Rev Cell Dev Biol 22:487- 508.
45. Lin JH, Walter P, Yen TS (2008) Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol 3:399-425. (Pubitemid 351488287)
46. Malhotra JD, Kaufman RJ (2007) The endoplasmic reticulum and the unfolded protein response. Semin Cell Dev Biol 18:716-731. (Pubitemid 350138453)
47. Mori K (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell 101:451-454.
48. Kleizen B, Braakman I (2004) Protein folding and quality control in the endoplasmic reticulum. Curr Opin Cell Biol 16:343-349. (Pubitemid 38903139)
49. Zhang K, Kaufman RJ (2006) The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology 66:S102-S109. (Pubitemid 43739994)
50. Marciniak SJ, Ron D (2006) Endoplasmic reticulum stress signaling in disease. Physiol Rev 86:1133-1149. (Pubitemid 44521649)
51. Szegezdi E, Logue SE, Gorman AM, Samali A (2006) Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 7:880-885. (Pubitemid 44523966)
52. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J (2000) Caspase 12 mediates ER-specific apoptosis and cytotoxicity by amyloid-β. Nature 403:98-103. (Pubitemid 30038529)
53. Kalai M, Lamkanfi M, Denecker G, Boogmans M, Lippens S, Meeus A, Declercq W, Vandenabeele P (2003) Regulation of the expression and processing of caspase 12. J Cell Biol 162:457-467.
54. Oyadomari S, Mori M (2004) Role of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ 11:381-389. (Pubitemid 38489416)
55. Kondo S, Barna BP, Kondo Y, Tanaka Y, Casey G, Liu J, Morimura T, Kaakaji R, Peterson JW, Werbel B, Barnett GH (1996) WAF1/CIP1 increases the susceptibility of p53 nonfunctional malignant glioma cells to cisplatin-induced apoptosis. Oncogene 13:1279-1285. (Pubitemid 26343581)
56. Lincet H, Poulain L, Remy JS, Deslandes E, Duigou F, Gauduchon P, Staedel C (2000) The p21(cip1/waf1) cyclin-dependent kinase inhibitor enhances the cytotoxic effect of cisplatin in human ovarian carcinoma cells. Cancer Lett 161:17-26.
57. Franklin DS, Godfrey VL, Lee H, Kovalev GI, Schoonhoven R, Chen-Kiang S, Su L, Xiong Y (1998) CDK inhibitors p18INK4c and p27Kip1 mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev 12:2899-2911. (Pubitemid 28440148)
58. Al-Mohanna MA, Manogaran PS, Al-Mukhalafi Z, A Al-Hussein K, Aboussekhra A (2004) The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 23:201-212. (Pubitemid 38142254)
59. Le HV, Minn AJ, Massagué J (2005) Cyclin-dependent kinase inhibitors uncouple cell cycle progression from mitochondrial apoptotic functions in DNA-damaged cancer cells. J Biol Chem 280:32018-32025. (Pubitemid 41291953)
60. Scassa ME, Marazita MC, Ceruti JM, Carcagno AL, Sirkin PF, González-Cid M, Pignataro OP, Cánepa ET (2007) Cell cycle inhibitor, p19INK4d, promotes cell survival and decreases chromosomal aberrations after genotoxic insult due to enhanced DNA repair. DNA Repair 6:626-638. (Pubitemid 46518331)
61. Tavera-Mendoza LE, Wang TT, White JH (2006) p19INK4D and cell death. Cell Cycle 5:596-598.
62. Massagué J (2004) G1 cell-cycle control and cancer. Nature 432:298-306. (Pubitemid 39551657)
63. Trimarchi JM, Lees JA (2002) Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3:11-20. (Pubitemid 135709914)